Role of polyunsaturated fatty acids in Japanese patients with coronary spastic angina.
Abstract
BACKGROUND
n-3 polyunsaturated fatty acids (PUFAs) reduce the risk of ischemic heart disease. However, there are few reports of a relationship between n-3 PUFAs and coronary spastic angina (CSA). This study aimed to assess the age-dependent role of serum levels of fatty acid in patients with CSA.
METHODS AND RESULTS
We enrolled 406 patients who underwent ergonovine tolerance test (ETT) during coronary angiography for evaluation of CSA. All ETT-positive subjects were diagnosed as having CSA.
We categorized the patients by age and results of ETT as follows
(1) young (age=65years) CSA-positive (n=32), (2) young CSA-negative (n=134), (3) elderly (age>66years) CSA-positive (n=36), and (4) elderly CSA-negative (n=204) groups. We evaluated the serum levels of eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA), arachidonic acid, and dihomo-gamma-linolenic acid. In the young groups, the serum levels of epa (64.3+/-37.7mug/mL vs. 49.4+/-28.8mug/mL, p=0.015) and DHA (135.7+/-47.6mug/mL vs. 117.4+/-37.6mug/mL, p=0.020) were significantly higher in the CSA-positive group than in the CSA-negative group, respectively. However, this was not the case with elderly groups. In the multivariate analysis in young groups, the serum levels of epa (p=0.028) and DHA (p=0.049) were independently associated with the presence of CSA, respectively.
CONCLUSION
Our results suggested that the higher serum levels of epa and/or DHA might be involved in the pathophysiology of CSA in the young population but not in the elderly population.